Date of event: unknown.The date received by manufacturer has been used for this field.(b)(4).Investigation summary: a device history record review was completed by our quality engineer team for provided lot number 0286402.The review did not reveal any detected abnormalities during the production process that could have contributed to this defect and all quality tests were found to be within specification.To aid in the investigation of this issue, both picture and physical samples were returned for evaluation by our quality engineer team.Investigation conclusion: through examination of the samples, damage was observed to the product packaging.Upon receipt of this report, an awareness training session was performed with all applicable associates in regards to this defect.An increase in the frequency of in-process inspections has been temporarily established to monitor for the presence of this type of damage during the manufacturing process.A corrective and preventive action plan has been initiated to further investigate this issue and ensure that the corrective actions are addressing the issue properly.Root cause description: at this time, a single cause for this type of damage has not been assigned.Rationale: the existing capa (b)(4).Has been raised to track the corrective actions established for top web damage issue.The issue is being investigated with plant engineering leadership, and while a single root cause is unassignable, the capa has utilized ishikawa assessments and the current focus of the investigation is on the handling and packaging of the blisters.Corrective and preventive actions shall continue to be tracked through capa (b)(4).
|
It was reported that syringe 10ml reg pr saline fill spkg package was damaged on 19 occasions and the label was smeared.The following information was provided by the initial reporter: material no: 306553, batch no: 0286402.It was reported 9 out of the 19 syringes have large holes in the sterility packaging, 10 out of 19 had the sterility packaging completely worn.The packaging was so worn that even the letters on the packaging had faded.We received shipment and opened up the box to inspect the materials & we found 19 of these syringes had to be we rejected.9 out of the 19 have large holes in the sterility packaging, complete breaches of the sterile barrier; 10 out of 19 had the sterility packaging completely worn from shipping and were about to tear.The packaging was so worn that even the letters on the packaging had faded.
|